DIABETES in the COMMUNITY

 

 

NEWS

HOMETHE DIABETES SHOPTHE DIABETIC BOOK SHOPUNDERSTANDING DIABETESMANAGING DIABETESLIVING WITH DIABETESCOMPLICATIONS OF DIABETESALL ABOUT INSULINDRUGS AND NEW PRODUCTSFUNDRAISING EVENTSLINKSSUPPORT GROUPNEWSCONTACT USFORUMRECIPESDIABETES UKFEEDBACKNEWSLETTEREMAIL USYOUR STORIESYOUR HOROSCOPECALENDARDIABETES IN PETS

 

 

News

On this page, we will announce news and local events relating to Diabetes . We will also present new developments and research initiatives from throughout the world of diabetes.

High prevalence of Diabetes in Birmingham, UK

18 April 2008

Research published at the Diabetes UK conference in Spring 2008 show a high prevalence of diabetes in Birmingham. The Deadly Trio project reported that nearly 15% of men over the age of 40 years have diabetes in Birmingham. This figure is 9% higher than the national average. It was thought the high prevalence of T2D is due to obesity and high levels of deprivation.

ref: Poster 362, Diabetes UK, March 2008. Detecting undiagnosed diabetes in men using the deadly Trio Project.

Major study does not confirm increased risk of death reported by US trial

25 March 2008

Preliminary results of the ADVANCE Study, a large diabetes trial involving over 11,000 high risk patients with type 2 diabetes, show no evidence of an increased risk of death among patients receiving intensive treatment to lower blood glucose.

In the ADVANCE study, the intensive blood glucose lowering program aimed to reduce HbA1c to below 6.5%. In view of the unexpected report from the ACCORD trial (see news item 27th February), the investigators in the ADVANCE study looked at their data to assess whether there was any evidence to support the suggestion that intensive blood glucose lowering may increase mortality.

No evidence that Cinnamon is of benefit in diabetes

28 February 2008

A meta-anlaysis published in Diabetes Care has shown that Cinnamon does not appear to improve A1C, fasting blood glucose, or lipids in people with type 1 or type 2 diabetes. The study was a statistical analysis of published evidence to date and included five prospective randomised studies involving 282 subjects.

Reference: Effect of Cinnamon on Glucose Control and Lipid Parameters Baker et al, Diabetes Care 31:41-43, 2008

Software developed to help identify undiagnosed diabetes

28 February 2008

It has been known for several years that there are potentially a large number of people in the UK who have undiagnosed diabetes. Diabetes is a condition which may develop without causing any symptoms. In the absence of a programme for routine screening it is recognised that a siginificant number of people may remain undiagnosed for several years.

A study published in the British Journal of General Practice has reported the results of using software to detect 'missed' diabetes in General Practice.

The work done by a team from the University of Warwick, University of Nottingham, Imperial College London and EMIS a software provider, showed that using the software to analyse data held on General Practice Computer databases, helped identify people with high blood glucose levels in whom a diagnosis of diabetes had not been formally made.

 

ACCORD Diabetes Study halted prematurely

27 February 2008

A large Diabetes study funded by the National Heart Lung and Blood Institute in the USA, was abandoned prematurely due to an unexplained disparity in death rate noted in one section of the study.

The ACCORD study (Action to Control Cardiovascular Risk in Diabetes) recruited people with Type 2 diabetes who were at high risk of heart attacks or stroke. One part of this study was to examine the benefit of intensive blood glucose control in this group of patients compared with more standard blood glucose treatment.

In the group of patient who were intensively treated, death rates were 20% higher than in the group on conventional treatment. The study has not been published as yet. However, an editorial in the Journal of the Endocrine Society reports that this is a difference of 3 deaths for every 1000 participants per year, over an average of four years of treament. It is also reported that death rates in both groups were lower than expected.

The reasons for the difference in mortality rates is not known. The people particpating in the ACCORD study were those at very high risk of heart attack and stroke. They had a history of diabetes for ten years and average age of subjects was over 60 years. More information may emerge when full details of the study are published.

 

Research shows Metformin prevents Diabetes

21 February 2008

Research published in the February edition of the American Journal of Medicine has shown that Metformin may be beneficial if you are at risk of type 2 diabetes.

A meta-analysis of over thirty previously published studies which used Metformin in over four and a half thousand people without diabetes has shown that using Metformin in persons at risk for diabetes improves weight, lipid profiles, and insulin resistance, and reduces new-onset diabetes by 40%.

A meta-analysis refers to a detailed study of several publications using statistical methods to identify trends.

Approval for expanded use of Januvia in Type 2 Diabetes

20 February 2008

The European Licensing authorities have approved the use of Januvia (sitagliptin) in combination with sulphonylureas or sulphonylurea plus metformin. This means that Januvia may now be used as 'triple therapy'.

The change in guidance is based on evidence from phase III clinical trials which suggest that sitagliptin 100 mg once daily in combination with glimepiride (a sulphonylurea) alone or with glimepiride plus metformin is well tolerated and effective.

Pancreatic Islet call transplantation in the UK from 1st April 2008

20 February 2008

It is anticipated that the Department of Health is to fund a national programme of pancreatic islet cell transplantation from the beginiing of April, this year. Six centres are planned, three of which, Oxford, King's and the Royal Free Hospital will be isolating islets and three centres in Bristol, Manchester and Newcastle will be transplanting the islets. These three centres will provide coverage to the whole of the UK.

Two categories of patients are likely to be considered for transplants. Those with Type 1 diabetes who are unstable due to frequent hypoglycaemia with poor warning symptoms and those patients who have already had a renal transplant and are therefore immunosuppressed. In the latter group, and islet cell transplant could provide a major benefit with very little risk attached.

 

Diabetic mice 'cured' with drugs
Diabetes patient
Diabetes is managed with regular insulin injections
US scientists have managed to rid diabetic mice of the effects of the disease using a cocktail of drugs.

The mice, who had type 1 diabetes, started producing their own insulin after taking a mixture of four drugs.

Previously the same team at Harvard University had only been able to stop the destruction of the cells which make insulin, not regenerate them.

But in a study reported in the New Scientist, they say adding another drug to the original cocktail did just that.

They now hope to start trials in humans.

Type 1 diabetes is usually managed through regular injections of insulin and until now, research into a cure has focused on transplanting the pancreatic beta cells which produce the hormone from donors.

However this is complicated - both because of the difficulty in finding a donor and the problems of rejection - so regenerating a person's own cells is seen as far better option.

Extra enzyme

Last year, Dr Terry Strom and his team demonstrated that they could stop the on-going destruction of insulin-producing beta cells in mice using a combination of three drugs, although they were unable to regenerate the cells.

It is exciting that these drugs could stop the immune system from attacking insulin-producing cells, but it is too early to tell whether these cells recovered in the mice or if new cells were produced
 
Iain Frame
Diabetes UK

However, when they added an extra ingredient - an enzyme called alpha 1 anti-trypsin - a significant rise in the number of beta cells was seen.

It is thought this extra drug may ease the inflammation of pancreas, a key feature of the disease.

"It would appear that by altering the inflammatory state that surrounds this autoimmune disease, you can create an environment that enables expansion of the beta cell mass," said Dr Strom.

He added that it was too early to say whether the beta cells which had stopped making insulin had recovered, or whether new ones were being produced.

Dr Iain Frame, director of research at Diabetes UK said: "This could potentially be very important research in finding a better treatment for diabetes.

"More research is needed as initial studies have only been conducted in mice, but Diabetes UK is pleased that clinical trials are planned and look forward to hearing the results."
 

 

 

Testosterone gel benefits

 

BACK TO TOP

SITEMAP

Copyriht DIABETESCOMMUNITY.ORG.UK 2008